NATCO PHARMA
|
The Current P/S Ratio of NATCO PHARMA is 3.74.
Share Price | ₹924.2 | Jun 12,2025 |
Market Cap | ₹16,551.5 Cr | |
Sales-TTM | ₹4,429.5 Cr | TTM-Consolidated Results |
Price/Sales | 3.74x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of NATCO PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹16,551.5 Cr] as on Jun 12,2025
(/) Sales [ ₹4,429.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.74x ]
Thus, for NATCO PHARMA , the investors are currently willing to pay '3.74 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of NATCO PHARMA !
The chart below summarizes the trend in P/S Ratio of NATCO PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of NATCO PHARMA
PS Ratio Performance Analysis for NATCO PHARMA
- NATCO PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 5.46x.
- NATCO PHARMA 's operated at median p/e ratio of 4.81x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NATCO PHARMA 's p/e ratio peaked in Mar2021 at 7.34x.
- NATCO PHARMA 's p/e ratio hit its five-year low in Mar2023 of 3.8x.
How does NATCO PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
NATCO PHARMA | 4,429.5 | 3.74 | 16,551.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.70 | 404,768.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 19.07 | 178,468.0 |
CIPLA LTD | 27,547.6 | 4.40 | 121,326.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 9.58 | 110,345.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.48 | 113,757.0 |
MANKIND PHARMA LTD | 12,279.3 | 8.02 | 98,512.2 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.24 | 98,470.1 |
LUPIN LTD | 22,707.9 | 4.07 | 92,350.7 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.11 | 67,082.6 |
ABBOTT INDIA LTD | 6,409.2 | 10.44 | 66,883.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NATCO PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.11x |
Max industry PS | 19.07x |
Median industry PS | 4.40x |
Average industry PS | 6.99x |
You may also like the below Video Courses